MedTrace Logo

Prospective Study Looking at Quality of Life Measures in Non-ischaemic Cardiomyopathy After Mitral Valve Repair

NCT00483236 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-10-12

No results posted yet for this study

Summary

* Chronic severe mitral regurgitation can lead to symptoms and left ventricular dysfunction.
* The purpose of this study is to prospectively follow patients with non-ischaemic cardiomyopathy who are eligible for mitral valve repair surgery and primarily measure the quality of life through the Minnesota Living with Heart Failure Questionnaire \& the Kansas City Cardiomyopathy Questionnaire.

Conditions

  • Mitral Valve Insufficiency
  • Dilated Cardiomyopathy
  • Congestive Heart Failure

Sponsors & Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Nadia Giannetti, MD.,FRCPC · Director of Heart Failure and Transplant Centre at McGill University Health Centre

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-01
Primary Completion
2009-06-01
Completion
2009-06-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483236 on ClinicalTrials.gov